Kelly Lawrence W & Associates Inc Viatris Inc Transaction History
Kelly Lawrence W & Associates Inc
- $429 Million
- Q1 2024
A detailed history of Kelly Lawrence W & Associates Inc transactions in Viatris Inc stock. As of the latest transaction made, Kelly Lawrence W & Associates Inc holds 2,467 shares of VTRS stock, worth $25,607. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,467
Previous 2,591
4.79%
Holding current value
$25,607
Previous $28,000
3.57%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding VTRS
# of Institutions
1,099Shares Held
945MCall Options Held
3.49MPut Options Held
2.6M-
Vanguard Group Inc Valley Forge, PA142MShares$1.47 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY93.3MShares$969 Million0.03% of portfolio
-
State Street Corp Boston, MA62.8MShares$651 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD57.9MShares$601 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$596 Million3.85% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.6B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...